Merck & Co has reached civil settlements with attorneys general from 29 states and the District of Columbia to fully resolve previously disclosed investigations under state consumer protection laws related to past activities for Vioxx.
Subscribe to our email newsletter
As part of the civil resolution of these investigations, Merck has agreed to pay a total of $58 million to be divided among the 29 states and the District of Columbia. In April, Merck announced it had taken a pre-tax charge in the first quarter of $55 million in anticipation of this settlement. The agreement also includes compliance measures that supplement policies and procedures previously established by the company.
Bruce Kuhlik, executive vice president and general counsel of Merck, said: “Merck remains committed to communications that help patients and their physicians choose medicines based on accurate, fair and balanced information.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.